These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24415919)

  • 1. An evaluation of pharmacogenomic information provided by five common drug information resources.
    Vaughan KT; Scolaro KL; Anksorus HN; Roederer MW
    J Med Libr Assoc; 2014 Jan; 102(1):47-51. PubMed ID: 24415919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of popular drug information resources on clinically useful and actionable pharmacogenomic information.
    Chang JS; Pham DA; Dang MT; Lu Y; VanOsdol S; Shin J
    J Med Libr Assoc; 2016 Jan; 104(1):58-61. PubMed ID: 26807054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of the Food and Drug Administration Pregnancy and Lactation Labeling Rule on Drug Information Resources.
    Harris JB; Holmes AP; Eiland LS
    Ann Pharmacother; 2021 Apr; 55(4):459-465. PubMed ID: 32885981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2013 Dec; 38(6):468-75. PubMed ID: 23895776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of resources for analyzing drug interactions.
    Patel RI; Beckett RD
    J Med Libr Assoc; 2016 Oct; 104(4):290-295. PubMed ID: 27822150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of online drug databases to assist in clinical decision-making with infectious disease therapies.
    Polen HH; Zapantis A; Clauson KA; Jebrock J; Paris M
    BMC Infect Dis; 2008 Nov; 8():153. PubMed ID: 18990224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Off-label use information in electronic drug information resources.
    Rothgeb A; Beckett RD; Daoud N
    J Med Libr Assoc; 2022 Oct; 110(4):471-477. PubMed ID: 37101928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
    Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
    Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the content and primary literature support for online medication information provided by Lexicomp and Wikipedia.
    Hunter JA; Lee T; Persaud N
    J Med Libr Assoc; 2018 Jul; 106(3):352-360. PubMed ID: 29962913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of five full-text drug databases by pharmacy students, faculty, and librarians: do the groups agree?
    Kupferberg N; Jones Hartel L
    J Med Libr Assoc; 2004 Jan; 92(1):66-71. PubMed ID: 14762464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of drug information resources for interactions between therapeutic drugs and drugs of abuse.
    Beckett RD; Martin JR; Stump CD; Dyer MA
    J Med Libr Assoc; 2020 Oct; 108(4):584-590. PubMed ID: 33013215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view.
    Varnai R; Szabo I; Tarlos G; Szentpeteri LJ; Sik A; Balogh S; Sipeky C
    Pharmacogenomics J; 2020 Jun; 20(3):380-387. PubMed ID: 31787752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs.
    Vivot A; Boutron I; Ravaud P; Porcher R
    Genet Med; 2015 Sep; 17(9):733-8. PubMed ID: 25521333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical decision support tools: performance of personal digital assistant versus online drug information databases.
    Clauson KA; Polen HH; Marsh WA
    Pharmacotherapy; 2007 Dec; 27(12):1651-8. PubMed ID: 18041886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical decision support tools: analysis of online drug information databases.
    Clauson KA; Marsh WA; Polen HH; Seamon MJ; Ortiz BI
    BMC Med Inform Decis Mak; 2007 Mar; 7():7. PubMed ID: 17346336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomic biomarker information in FDA-approved paediatric drug labels.
    Kim T; Han N; Sohn M; Oh JM; Lee EK; Ji E; Kim IW
    Basic Clin Pharmacol Toxicol; 2015 May; 116(5):438-44. PubMed ID: 25348905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of drug information resources for drug-ethanol and drug-tobacco interactions.
    Beckett RD; Stump CD; Dyer MA
    J Med Libr Assoc; 2019 Jan; 107(1):62-71. PubMed ID: 30598650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobile Medical Applications for Dosage Recommendation, Drug Adverse Reaction, and Drug Interaction: Review and Comparison.
    Apidi NA; Murugiah MK; Muthuveloo R; Soh YC; Caruso V; Patel R; Ming LC
    Ther Innov Regul Sci; 2017 Jul; 51(4):480-485. PubMed ID: 30227053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
    Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
    Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improvement of package insert CYP information for prescription drugs marketed in Japan].
    Hirata-Koizumi M; Saito M; Urano T; Miyake S; Hasegawa R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):12-8. PubMed ID: 16541745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.